|Bid||137.25 x 900|
|Ask||138.23 x 900|
|Day's Range||132.96 - 138.95|
|52 Week Range||127.02 - 191.75|
|Beta (5Y Monthly)||0.21|
|PE Ratio (TTM)||39.89|
|Earnings Date||Apr 28, 2022 - May 02, 2022|
|Forward Dividend & Yield||4.64 (2.93%)|
|Ex-Dividend Date||Apr 26, 2022|
|1y Target Est||137.93|
I'm a big fan of great companies when investors aren't showing them much love. These two dividend stocks are squarely in that boat today.
The dollar is on a roll, thanks to the surge in U.S. interest rates, a strong U.S. economy and the war in Ukraine. The rise in rates helps the greenback because they make dollar-denominated fixed-income instruments more attractive.
In the current market evironment, investors could find solid ground with this dividend stocks to buy. Merck (MRK): Robust results across its core portfolio, with its oncology portfolio expected to fire on all cylinders. Chevron (CVX): Cash flow generating machine, which will benefit immensely from rising oil prices. Clorox (CLX): Attractive income stock, which has seen dividends grow every year since 1977. Procter and Gamble (PG): Consistent performer that has been on a roll of late. AbbVie (ABB